Literature DB >> 14044094

CHANGES IN THE MOUSE'S ENTERIC MICROFLORA ASSOCIATED WITH ENHANCED SUSCEPTIBILITY TO SALMONELLA INFECTION FOLLOWING STREPTOMYCIN TREATMENT.

C P MILLER, M BOHNHOFF.   

Abstract

Entities:  

Keywords:  AEROBACTER AEROGENES; BACTEROIDES; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; FUNGI; INTESTINAL MICROORGANISMS; LACTOBACILLUS; MICE; PARACOLOBACTRUM; PROTEUS; PSEUDOMONAS; SALMONELLA INFECTIONS, ANIMAL; STREPTOMYCIN; YEASTS

Mesh：

Substances：

Year:  1963        PMID： 14044094     DOI： 10.1093/infdis/113.1.59

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  62 in total

1.  Immunity to enteric infection in mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

2.  Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources.

Authors:  Mary P Leatham; Sarah J Stevenson; Eric J Gauger; Karen A Krogfelt; Jeremy J Lins; Traci L Haddock; Steven M Autieri; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Bacterial interference by anaerobic species isolated from human feces.

Authors:  M P Wilhelm; D T Lee; J E Rosenblatt
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

Review 4.  Customizing laboratory mice by modifying gut microbiota and host immunity in an early "window of opportunity".

Authors:  Camilla H F Hansen; Stine B Metzdorff; Axel K Hansen
Journal:  Gut Microbes       Date:  2013-04-02

5.  Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.

Authors:  B A McCormick; D P Franklin; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract.

Authors:  C Poppe; L C Martin; C L Gyles; R Reid-Smith; P Boerlin; S A McEwen; J F Prescott; K R Forward
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

Review 7.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

8.  Genes of the GadX-GadW regulon in Escherichia coli.

Authors:  Don L Tucker; Nancy Tucker; Zhuo Ma; John W Foster; Regina L Miranda; Paul S Cohen; Tyrrell Conway
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

9.  Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine.

Authors:  Regina L Miranda; Tyrrell Conway; Mary P Leatham; Dong Eun Chang; Wendy E Norris; James H Allen; Sarah J Stevenson; David C Laux; Paul S Cohen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.

Authors:  D A Hill; C Hoffmann; M C Abt; Y Du; D Kobuley; T J Kirn; F D Bushman; D Artis
Journal:  Mucosal Immunol       Date:  2009-11-25       Impact factor: 7.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.